Systemic exposure of everolimus after stent implantation: a pharmacokinetic study.
D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D019540:Area Under Curve; D002851:Chromatography, High Pressure Liquid; D003327:Coronary Disease / Q000628:therapy*; D003925:Diabetic Angiopathies / Q000628:therapy*; D054855:Drug-Eluting Stents; D000068338:Everolimus; D005260:Female; D006207:Half-Life; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics*; D008297:Male; D008875:Middle Aged; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics
D007166:Immunosuppressive Agents; D000068338:Everolimus; D020123:Sirolimus